2022
DOI: 10.1016/j.nicl.2022.103133
|View full text |Cite
|
Sign up to set email alerts
|

Diffusion spectrum imaging of patients with middle cerebral artery stenosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 32 publications
0
2
0
Order By: Relevance
“…With the improvement in DSI data acquisition, more attention has recently been paid to its application in clinical diseases, including attention-deficit/hyperactivity disorder (ADHD) [2,64,65], schizophrenia [66][67][68], stroke [69][70][71][72], Parkinson's disease [73,74], hypertension [75], autism [76], epilepsy [77], and gliomas [78] (see Table 2).…”
Section: Clinical Applicationsmentioning
confidence: 99%
“…With the improvement in DSI data acquisition, more attention has recently been paid to its application in clinical diseases, including attention-deficit/hyperactivity disorder (ADHD) [2,64,65], schizophrenia [66][67][68], stroke [69][70][71][72], Parkinson's disease [73,74], hypertension [75], autism [76], epilepsy [77], and gliomas [78] (see Table 2).…”
Section: Clinical Applicationsmentioning
confidence: 99%
“…Middle cerebral artery (MCA) atherosclerotic stenosis is an important cause of recurrent cerebral ischemic strokes (1)(2)(3)(4)(5)(6), and stent angioplasty is a valuable approach for treatment of severe MCA stenosis, mainly by endovascular revascularization to improve cerebral blood flow perfusion and prevent the occurrence of MCA stenosis-related hypoperfusion cerebral infarction (7,8). The Enterprise stent (Codman, Raynham, MA) was the second one to receive US FDA approval for stentassisted coiling and the first one with a closed-cell design.…”
Section: Introductionmentioning
confidence: 99%